Skip to main content
Figure 3 | BMC Cardiovascular Disorders

Figure 3

From: The preventive effect of atorvastatin on atrial fibrillation: a meta-analysis of randomized controlled trials

Figure 3

Primary and secondary prevention of AF with atorvastatin. AF: atrial fibrillation; ARMYDA-3: atorvastatin for reduction of myocardial dysrhythmia after cardiac surgery study; CI: confidence interval; MIRACL: myocardial ischemia reduction with aggressive cholesterol lowering study; SPARCL: Stroke Prevention by Aggressive Reduction in Cholesterol Levels; SToP AF: statin therapy for the prevention of atrial fibrillation trial.

Back to article page